Body Weight  >>  Invokana (canagliflozin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Invokana (canagliflozin) / J&J, Daiichi Sankyo, Mitsubishi Tanabe
NCT02360774: Mechanisms of Weight Loss With SGLT2 Inhibition

Completed
4
30
US
Canagliflozin, Invokana, Placebo
Beth Israel Deaconess Medical Center, Janssen Scientific Affairs, LLC
Type 2 Diabetes, Overweight, Obesity
08/18
08/18

Download Options